Home NDC 73116-215 COPIKTRA
Product NDC 73116-215
11-digit product format 731160215
Labeler code 73116
Product ID 73116-215_30ff13f0-1e77-43de-99c9-c309834f1e63
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name duvelisib
Dosage form CAPSULE
Route ORAL
Labeler Secura Bio, Inc
Application NDA211155
Marketing category NDA
Marketing start 2018-09-25
Substance DUVELISIB
Active strength 15 mg/1
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N211155-001 COPIKTRA DUVELISIB 15MG CAPSULE / ORAL RLD 2018-09-24 N211155-002 COPIKTRA DUVELISIB 25MG CAPSULE / ORAL RLD 2018-09-24
Orange Book patents# Current patent rows page 1 of 1 · 16 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N211155-001 9216982 2029-01-05 U-2412 2018-10-23 N211155-001 9216982 2029-01-05 U-2413 2018-10-23 N211155-001 11312718 2032-01-10 Drug product 2022-06-03 N211155-001 9840505 2032-01-10 U-2412 2018-10-23 N211155-001 9840505 2032-01-10 U-2413 2018-10-23 N211155-001 RE46621 2032-05-17 Drug substance, Drug product 2018-10-23 N211155-001 8193182 2032-09-24 Drug substance 2018-10-23 N211155-001 12213983 2035-04-26 U-2412 2025-03-05 N211155-002 9216982 2029-01-05 U-2412 2018-10-23 N211155-002 9216982 2029-01-05 U-2413 2018-10-23 N211155-002 11312718 2032-01-10 Drug product 2022-06-03 N211155-002 9840505 2032-01-10 U-2412 2018-10-23 N211155-002 9840505 2032-01-10 U-2413 2018-10-23 N211155-002 RE46621 2032-05-17 Drug substance, Drug product 2018-10-23 N211155-002 8193182 2032-09-24 Drug substance 2018-10-23 N211155-002 12213983 2035-04-26 U-2412 2025-03-05
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 84e616aacf4f…2026-08-18 06:07:40 2026-07 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD 2018-09-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD, RS 2018-09-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD, RS 2018-09-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N211155-001 COPIKTRA 15MG CAPSULE / ORAL RLD 2018-09-24 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N211155-002 COPIKTRA 25MG CAPSULE / ORAL RLD, RS 2018-09-24 74a2ff9319b5…
Observed Orange Book patent history# Patent history page 1 of 15 · 592 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N211155-001 9216982 2029-01-05 U-2413 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-001 9216982 2029-01-05 U-2412 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-001 11312718 2032-01-10 Drug product 2022-06-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-001 9840505 2032-01-10 U-2413 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-001 9840505 2032-01-10 U-2412 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-001 RE46621 2032-05-17 Drug substance, Drug product 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-001 8193182 2032-09-24 Drug substance 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-001 12213983 2035-04-26 U-2412 2025-03-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-002 9216982 2029-01-05 U-2413 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-002 9216982 2029-01-05 U-2412 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-002 11312718 2032-01-10 Drug product 2022-06-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-002 9840505 2032-01-10 U-2412 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-002 9840505 2032-01-10 U-2413 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-002 RE46621 2032-05-17 Drug substance, Drug product 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-002 8193182 2032-09-24 Drug substance 2018-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211155-002 12213983 2035-04-26 U-2412 2025-03-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 N211155-001 9216982 2029-01-05 U-2413 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-001 9216982 2029-01-05 U-2412 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-001 11312718 2032-01-10 Drug product 2022-06-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-001 9840505 2032-01-10 U-2413 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-001 9840505 2032-01-10 U-2412 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-001 RE46621 2032-05-17 Drug substance, Drug product 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-001 8193182 2032-09-24 Drug substance 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-001 12213983 2035-04-26 U-2412 2025-03-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-002 9216982 2029-01-05 U-2413 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-002 9216982 2029-01-05 U-2412 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-002 11312718 2032-01-10 Drug product 2022-06-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-002 9840505 2032-01-10 U-2412 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-002 9840505 2032-01-10 U-2413 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-002 RE46621 2032-05-17 Drug substance, Drug product 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-002 8193182 2032-09-24 Drug substance 2018-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211155-002 12213983 2035-04-26 U-2412 2025-03-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211155-001 9216982 2029-01-05 U-2413 2018-10-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211155-001 9216982 2029-01-05 U-2412 2018-10-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211155-001 8193182 2030-02-13 Drug substance 2018-10-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211155-001 11312718 2032-01-10 Drug product 2022-06-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211155-001 9840505 2032-01-10 U-2413 2018-10-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211155-001 9840505 2032-01-10 U-2412 2018-10-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211155-001 RE46621 2032-05-17 Drug substance, Drug product 2018-10-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211155-001 12213983 2035-04-26 U-2412 2025-03-05 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 4 · 154 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base COPIKTRA
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DUVELISIB 15 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 610V23S0JI Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2058514 Internal RxNorm lookup 2058520 Internal RxNorm lookup 2058523 Internal RxNorm lookup 2058525 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 73116-215-28 COPIKTRA 28 in 1 PACKAGE CAPSULE 28 4 73116-215-56 COPIKTRA 56 in 1 PACKAGE CAPSULE 56 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 73116-215 COPIKTRA (DUVELISIB) CAPSULE [SECURA BIO, INC] 3 Current NDC, Legacy NDC, 2 package rows 20240806_e3c5ac56-e1f6-473a-bc73-687836534780.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 73116-215-28 73116021528 28 CAPSULE in 1 PACKAGE (73116-215-28) 28 capsule 2018-09-25 0000-00-00 No No Current 73116-215-56 73116021556 56 CAPSULE in 1 PACKAGE (73116-215-56) 56 capsule 2018-09-25 0000-00-00 No No Current